摘要
目的:探讨中医定向透药疗法佐治成人支原体肺炎的临床效果。方法:选取本院2018年5月至2019年5月收治的支原体肺炎患者180例,随机分为2组。对照组90例采用常规氟喹诺酮类抗生素治疗,观察组90例在常规治疗的基础上实施中医定向透药疗法。结果:实验组与对照组相比,临床疗效提高(97.78%VS 88.89%),退热时间缩短(2.60±1.07d VS 3.19±1.20d),咳嗽消失时间缩短(4.18±1.38d VS 6.06±1.77d),平均住院日缩短(7.42±1.57d VS 8.54±1.68d),CRP下降加快(治疗4天后复查CRP:9.85±7.69mg/L VS 16.61±14.46mg/L;治疗前后CRP差值:32.69±26.52mg/L VS 24.25±18.35mg/L(P<0.05))。结论:中医定向透药疗法佐治成人支原体肺炎的临床疗效显著。
[Objective]To study the clinical effect of directional drug therapy for adult Mycoplasma pneumonia.[Method] 180 Cases of Mycoplasma Pneumonia from May 2018 to May 2019 were random divided into two groups. In control group,90 cases were treated with routine fluoroquinolones. 90 patients in the observation group implemented traditional Chinese medicine targeted penetration therapy based on conventional treatment. [Result]Compared with the control group, the experimental group had improved clinical efficacy(97.78% vs88.89%, P<0.05), reduced fever time(2.60 ± 1.07 d vs 3.19 ± 1.20 d, P<0.05), and reduced cough disappearance time(4.18 ± 1.38 d vs 6.06 ± 1.77 d, P<0.05). Mean hospital stay was shortened(7.42 ± 1.57 d vs 8.54 ± 1.68 d, P <0.05). CRP decline accelerated(CRP review after 4 days of treatment: 9.85 ± 7.69 mg/L vs 16.61 ± 14.46 mg/L, P<0.05;CRP difference before and after treatment: 32.69 ± 26.52 mg/L vs 24.25 ± 18.35 mg/L, P<0.05). [Conclusion]The clinical effect of Chinese medicine directed drug therapy on adult Mycoplasma pneumonia is remarkable.
作者
钟跃
王红泉
陈叶辉
ZHONG Yue;WANG Hhongquan;CHEN Yehui(The First People's Hospital of Tongxiang,Zhejiang 314500,China)
出处
《浙江医学教育》
2020年第3期58-60,共3页
Zhejiang Medical Education
关键词
中医定向透药疗法
成人
支原体肺炎
临床效果
directional Chinese medicine penetration therapy
adult
mycoplasma pneumonia
clinical effect
